Literature DB >> 3932600

Free light chains in the cerebrospinal fluid: an indicator of recent immunological stimulation.

A Vakaet, E J Thompson.   

Abstract

A group of 38 patients with immunoglobulin free light chains (kappa and/or lambda) in the cerebrospinal fluid was studied. Only five of them showed one band of kappa free light chains, 36 of them showed one or more bands of lambda free light chains. There were 33 multiple sclerosis patients among them and they were compared with 33 control multiple sclerosis patients who did not have free light chains but only showed an oligoclonal pattern of immunoglobulins in their CSF. Of several clinical and pathological parameters, only three were statistically significant: (A) for all patients, as well as for the multiple sclerosis patients alone, elevated numbers of free light chains of type lambda were associated with the elevated numbers of white blood cells in the CSF (p less than 0.003), (B) for multiple sclerosis patients, elevated numbers of free light chains of type lambda were associated with associated with shorter time intervals between the last relapse and the date of the lumbar puncture (p less than 0.004) and (C) also with shorter duration of the disease (p less than 0.01). The presence of lambda free light chains in the cerebrospinal fluid seems to indicate that recent antigenic stimulation has occurred within the central nervous system following exacerbation. The inverse association of the number of lambda free light chains with the duration of the disease is suggestive of a pathological expression of the "burning out" phenomenon of the multiple sclerosis process.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3932600      PMCID: PMC1028537          DOI: 10.1136/jnnp.48.10.995

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS.

Authors:  J F KURTZKE
Journal:  Neurology       Date:  1965-07       Impact factor: 9.910

2.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

Review 3.  Diagnosis and classification of multiple sclerosis.

Authors:  W I McDonald; A M Halliday
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

4.  Bound and free light chains in subacute sclerosing panencephalitis and multiple sclerosis serum and cerebrospinal fluid.

Authors:  F Bollengier; A Lowenthal; W Henrotin
Journal:  Z Klin Chem Klin Biochem       Date:  1975-07

5.  Oligoclonal immunoglobulins and plasma cells in spinal fluid of patients with multiple sclerosis.

Authors:  E J Thompson; P Kaufmann; R C Shortman; P Rudge; W I McDonald
Journal:  Br Med J       Date:  1979-01-06

Review 6.  Laboratory diagnosis of multiple sclerosis: immunological and biochemical aspects.

Authors:  E J Thompson
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

7.  Bound and free light chains in serum from patients affected with various neurological diseases.

Authors:  F Bollengier
Journal:  J Clin Chem Clin Biochem       Date:  1979-01

8.  Neuroimmunology I: Immunoregulation in neurological disease.

Authors:  H L Weiner; S L Hauser
Journal:  Ann Neurol       Date:  1982-05       Impact factor: 10.422

9.  Cerebrospinal fluid immunoelectrophoresis in multiple sclerosis.

Authors:  O J Kolar; P H Rice; F H Jones; R J Defalque; J Kincaid
Journal:  J Neurol Sci       Date:  1980-08       Impact factor: 3.181

  9 in total
  12 in total

1.  Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry.

Authors:  Sophie Desplat-Jégo; Lionel Feuillet; Jean Pelletier; Dominique Bernard; André Ali Chérif; José Boucraut
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

2.  Urine free light chains in SLE: clonal markers of B-cell activity and potential link to in vivo secreted Ig.

Authors:  J E Hopper; J Golbus; C Meyer; G A Ferrer
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

3.  Free light chains in the CSF in multiple sclerosis.

Authors:  F Bracco; P Gallo; R Menna; L Battistin; B Tavolato
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

Review 4.  Cerebrospinal fluid.

Authors:  E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

5.  Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system.

Authors:  B N McLean; D Miller; E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-05       Impact factor: 10.154

6.  Patterns of blood-brain barrier impairment and clinical features in multiple sclerosis.

Authors:  B N McLean; A Z Zeman; D Barnes; E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-04       Impact factor: 10.154

Review 7.  The clinical use of cerebrospinal fluid studies in demyelinating neurological diseases.

Authors:  M G Harrington; P G Kennedy
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

8.  Immunoglobulin M in the cerebrospinal fluid: an indicator of recent immunological stimulation.

Authors:  M K Sharief; E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

9.  Experimental allergic encephalomyelitis in the monkey: humoral immunity and blood-brain barrier function.

Authors:  P Gallo; D Cupic; F Bracco; L Krzalic; B Tavolato; L Battistin
Journal:  Ital J Neurol Sci       Date:  1989-12

Review 10.  Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

Authors:  M Andersson; J Alvarez-Cermeño; G Bernardi; I Cogato; P Fredman; J Frederiksen; S Fredrikson; P Gallo; L M Grimaldi; M Grønning
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.